Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis. (18th November 2018) - Barone, Martina; Ricci, Francesca; Sollazzo, Daria; Ottaviani, Emanuela; Romano, Marco; Auteri, Giuseppe; Bartoletti, Daniela; Reggiani, Maria L. B.; Vianelli, Nicola; Tazzari, Pier L.; Cavo, Michele; Forte, Dorian; et al.